Artificial Intelligence

A new AI platform is the first to get EU approval for predicting fertility treatment timing, promising to boost success rates and ease clinic workloads.

Two leaders at a Canadian 3PL have been honored, proving human ingenuity and strategic vision are key to mastering the modern supply chain. Here's why.

Private equity firm STG acquires Carrier Logistics Inc. to build an AI-native operating system, aiming to revolutionize the LTL freight industry.

A landmark partnership with Blue Star Innovation Partners will fuel IntusCare's AI platform, aiming to revolutionize the complex, high-growth PACE market.

A defense IT specialist joins industry giants on a historic federal contract with no spending limit, set to redefine government technology for a decade.

A growing network of founder-led tech firms is proving that the best digital tools come from those who have worked on the jobsite. Here's how.

Calamos's new CAGE ETF brings a complex, high-growth institutional strategy to retail investors. But does this powerful innovation come with too much risk?

With key advisory appointments, NeuraClick aims to overcome long-standing hurdles in peptide drug development for complex brain and metabolic disorders.

As attackers use AI and proxies to hide in plain sight, Spur Intelligence's rapid growth shows why deep IP intelligence is becoming a top business priority.

After settling a major legal battle, Allied Gaming is ditching its past for an ambitious—and risky—future in AI, tokenization, and a new cryptocurrency.

A multi-million dollar contract for advanced hardware highlights the urgent race to secure critical data against the looming threat of quantum computing.

Aetrex and Tradehome Shoes will provide free 3D foot scans and custom orthotics to thousands of athletes at the 2026 Special Olympics USA Games.

With the hire of Tracy Thibodeau, Monjur doubles down on its strategy to blend AI efficiency with attorney oversight for the complex MSP market.

TEDCO's latest funding round seeds 13 university-born ventures, tackling everything from hereditary hearing loss and cancer to environmental monitoring.

A new biotech player is advancing a first-in-class cancer drug that combines two payloads to fight tumors that have become resistant to current therapies.

Apryse's new ICR technology lets companies digitize handwritten documents securely in-house, unlocking a final frontier of data for AI automation.

The struggling footwear brand is selling its assets to become NewBird AI, a GPU provider. Is it a visionary gamble or a desperate move in the AI gold rush?

A South Korean startup is set to mass-produce a breakthrough CXL 3.2 switch, promising to solve AI bottlenecks with unique Port-Based Routing technology.

Backed by Bain Capital and a veteran team, the new biotech has a de-risked pipeline from Bristol Myers Squibb aimed at transforming care for lupus and more.

Investors eye BioCryst's May 6th report for insights into ORLADEYO's growth, a pivotal acquisition, and its strategy in the competitive rare disease market.